文献速递脑血管病外科神经重症

立体定向放射外科、栓塞及保守治疗脑动静脉畸形的长期结局:新西兰经验

Stereotactic Radio Surgery, Embolization and Conservative Management for Cerebral Arteriovenous Malformation: A New Zealand Experience of Long-Term Outcomes.
PubMed 文献 · World Neurosurg · 2022-05-26

单纯放射外科和放射外科前栓塞的疾病特异性死亡率分别为1%和0%,低于保守治疗的6%(P=0.024);三组再出血率无显著差异。作者认为放射外科和放射外科前栓塞是安全有效的治疗,但需跨国前瞻性随机对照试验进一步明确。

要点

  • 单纯放射外科和放射外科前栓塞的疾病特异性死亡率分别为1%和0%,低于保守治疗的6%(P=0.024)。
  • 单纯放射外科和放射外科前栓塞的闭塞率分别为78%和70%。
  • 再出血率三组无显著差异:单纯放射外科4%、放射外科前栓塞0%、保守治疗8%。

核心结论

  • 研究结果提示,以闭塞率、再出血率和疾病特异性死亡率衡量,立体定向放射外科和放射外科前栓塞是脑动静脉畸形的安全有效治疗。
  • 作者提出需通过跨国、前瞻性、随机对照试验及长期随访进一步明确放射外科和放射外科前栓塞对比保守治疗的有效性和安全性。

研究设计与样本

  • 单中心回顾性综述,纳入接受单纯立体定向放射外科(239例)、放射外科前栓塞(37例)或保守治疗(83例)的脑动静脉畸形患者。
  • 收集人口学资料、Spetzler-Martin分级、放射外科剂量、闭塞情况、闭塞时间、影像学方法、再出血、疾病特异性死亡及放射外科后并发症。
  • 采用卡方独立性检验和单因素方差分析/Kruskal-Wallis检验进行统计分析。

主要发现

  • 闭塞率:单纯放射外科78%,放射外科前栓塞70%。
  • 再出血率:单纯放射外科4%、放射外科前栓塞0%、保守治疗8%,组间可比。
  • 疾病特异性死亡率:单纯放射外科1%、放射外科前栓塞0%,均显著低于保守治疗的6%(X2[2, n=358]=7.50,P=0.024)。
  • 放射外科后并发症仅见于单纯放射外科组,包括放射性坏死(5例)、海绵状血管畸形(2例)和卒中(1例)。
  • 闭塞率、再出血率和疾病特异性死亡率在儿童(<18岁)、非老年(18-59岁)和老年(≥60岁)年龄组间可比。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cerebral arteriovenous malformations (AVMs) can be treated by microsurgery, stereotactic radiosurgery (SRS) as a stand-alone procedure, or combining embolization and conservative management. This single-center, retrospective review explored the outcomes of patients treated with SRS alone, embolization before SRS (ESRS), or conservative management for cerebral AVMs. METHODS: Demographic details, Spetzler-Martin grade, SRS dose, obliteration, time to obliteration, imaging modality, rebleed, disease-specific mortality, and post-SRS complications were collected. Chi-square tests of independence and 1-way analysis of variance/Kruskal-Wallis tests were performed. RESULTS: Two-hundred and thirty-nine patients were treated with SRS alone, 37 were treated with ESRS, and 83 were conservatively managed. Obliteration rates were 78% (SRS alone) and 70% (ESRS). Rebleed rates were comparable among SRS alone (4%), ESRS (0%), and conservative management (8%). Disease-specific mortality rates were significantly lower for SRS alone (1%) and ESRS (0%) compared with conservative management (6%, X2 [2, n = 358] = 7.50, P = 0.024). Post-SRS complications occurred with SRS alone only and included radiation necrosis (n = 5), cavernous malformations (n = 2), and stroke (n = 1). Obliteration, rebleed, and disease-specific mortality rates were comparable among pediatric (<18 years), nonelderly (18-59 years), and elderly (≥60 years) age groups. CONCLUSIONS: Findings suggest that SRS and ESRS are safe and effective treatments for cerebral AVM (when quantified by obliteration, rebleed, and disease-specific mortality rates). With multinational, prospective, randomized controlled trials with long follow-up periods, the effectiveness and safety of SRS and ESRS compared with conservative management for AVM will be further clarified.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bethanabatla R, Spencer T, Kelly L, et al. Stereotactic Radio Surgery, Embolization and Conservative Management for Cerebral Arteriovenous Malformation: A New Zealand Experience of Long-Term Outcomes. World Neurosurg. 2022. PMID: 35643401. doi:10.1016/j.wneu.2022.05.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。